Good MorningEquity markets rebounded on Wednesday, but the move may be short-lived. Data due today may reinforce the idea of hot inflation and Fed hawkishness, pushing the timeline for rate cuts out another few months. Among the causes for concern is a spike in mortgage rates, with home buyers pulling back. Another is a risk to the banking sector due to higher for longer interest rates. The risk to small and regional banks is growing by the day, and some may not last until the FOMC decides lower rates are acceptable.
Among the data points due out today is Retail Sales. Retail Sales are expected to fall compared to last year but may outpace consensus due to higher prices at the register and lingering consumer resilience at home. On the one hand, a decline in retail sales may indicate the start of a larger economic slowdown, while on the other hand, a hot read will keep the Fed policy tight. In both cases risk for equities abounds. Featured: The options guide that actually starts at the beginning (Ad) 
|
Healthcare | |
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the medical sector occurred on December 8, 2023, when the U.S. FDA approved Casgevy, the first FDA-approved ... Read the Full Story |
|
From Our Partners | | More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily volume over 500,000 shares, and over $10 million in trailing revenue.
Only five stocks cleared every filter, spanning five different sectors. Two are profitable today, and one pays a substantial dividend.
The report also flags what could go wrong with each pick, including dilution and convertible debt. | | See the five stocks that survived this strict revenue screen |
|
Technology | |
There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a quarterly basis. However, it takes capital to buy and hold the underlying shares. If you already own stoc... Read the Full Story |
|
Energy | |
The oil refiners' exchange-traded fund (ETF), the VanEck Oil Refiners ETF (NYSEARCA: CRAK), is outperforming the broader Energy Select Sector SPDR Fund (NYSEARCA: XLE) on a one-month, three-month and one-year basis.
The top components in the CRAK ETF are Marathon Petroleum Corp. (NYSE: MPC), Val... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Healthcare | |
2024 is shaping up to be a pivotal year for the biotechnology industry.
In recent years, emergency Covid vaccines have ushered in several groundbreaking innovations that have changed the way drugs are developed and health care is administered. Advancements in the treatment of cancer, Alzheimer&rs... Read the Full Story |
|
Consumer Discretionary | |
There’s perhaps never been a divergence like it. While the tech-heavy Nasdaq index has tacked on almost 10% since the first week of January, shares of electric vehicle (EV) giant Tesla Inc (NASDAQ: TSLA) have sunk more than 20%. And the worst part for Tesla investors is that it hasn’t ... Read the Full Story |
|
|
Consumer Staples | |
The Kraft Heinz Company (NASDAQ: KHC) Q4 report is not the stuff of legend but reveals several details income investors should heed. Among them are improving margins, favorable guidance, and cash flow, which suggests an inflection point is at hand for this consumer staple. The takeaway is that Kra... Read the Full Story |
|
Healthcare | |
Past performance doesn't guarantee future results. Or does it?
The age-old investment disclaimer is certainly being put to the test this year. Some of last year's biggest winners are off to hot starts in 2024.
NVIDIA is the best example. After soaring 239% last year, the semiconductor leader is ... Read the Full Story |
|
Energy | |
As the overall market continues to ramp up and trade near all-time highs, one sector has quietly consolidated. The energy sector remains close to flat this year despite the recent melt-up experienced in the rest of the market.
As you are most likely aware, the energy sector and its many publicly... Read the Full Story |
|
Consumer Staples | |
Iconic prestige beauty products company Estée Lauder Co. Inc. (NYSE: EL) may be righting its ship, as evidenced by its latest earnings report. The consumer discretionary sector company offers skincare, fragrances, haircare and makeup products through over 20 well-known brands, including AVE... Read the Full Story |
|
Technology | |
Today’s market is led by one of the most confusing dynamics seen in the latest cycle; markets are hitting all-time highs while most stocks seem to be struggling to reach even their 52-week highs. Bond yields are going up in trader bets that the FED interest rate cuts will not be here as soon... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. | | View Today's Stock Pick |
|
